Who are ProQR Therapeutics N.V.'s main suppliers?

ProQR Therapeutics N.V. (PRQR) key suppliers include: Eli Lilly and Company, Eli Lilly and Company, Mirum Pharmaceuticals, Inc.. View the full supplier network at chainsifter.com/chain/PRQR.

Who are ProQR Therapeutics N.V.'s major customers?

ProQR Therapeutics N.V. (PRQR) key customers include: Eli Lilly and Company, Eli Lilly and Company, Ionis Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Mirum Pharmaceuticals, Inc. and 2 more. View the full customer network at chainsifter.com/chain/PRQR.

What sector is ProQR Therapeutics N.V. in?

ProQR Therapeutics N.V. (PRQR) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

ProQR Therapeutics N.V. Suppliers, Customers & Supply Chain (PRQR)

3Suppliers

7Customers

1Debt Items

20Related Chains

Source-Backed Evidence Depth

ProQR Therapeutics N.V. (PRQR) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

12Total relationships

2Distinct source URLs

4High confidence

0.755Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

ProQR Therapeutics N.V. Suppliers

Ticker	Name	Confidence	Evidence
LLY	Eli Lilly and Company	72%	— ( ) The effect of changes in foreign exchange rates — — — Other changes Interest expense — — Interest paid — — — Effect of waived loan agreements — — — Effect …
LLY	Eli Lilly and Company	72%	Reciprocal relationship from LLY graph: Reciprocal relationship from PRQR graph: — ( ) The effect of changes in foreign exchange rates — — — Other changes Interest expense — …
MIRM	Mirum Pharmaceuticals, Inc.	72%	Reciprocal relationship from MIRM graph: with such services. Under certain circumstances, we may be required to report some of these relationships to the FDA or comparable foreign regulatory authorit…

ProQR Therapeutics N.V. Customers

Ticker	Name	Confidence	Evidence
LLY	Eli Lilly and Company	85%	Reciprocal relationship from LLY graph: Reciprocal relationship from PRQR graph: Reciprocal relationship from LLY graph: Reciprocal relationship from PRQR graph: Reciprocal relationship from LLY grap…
LLY	Eli Lilly and Company	85%	— ( ) The effect of changes in foreign exchange rates — — — Other changes Interest expense — — Interest paid — — — Effect of waived loan agreements — — — Effect …
IONS	Ionis Pharmaceuticals, Inc.	72%	Reciprocal relationship from IONS graph: Reciprocal relationship from PRQR graph: upport of our third-party information technology providers, our ISM addresses areas such as: ● Assessment and treatme…
IONS	Ionis Pharmaceuticals, Inc.	72%	upport of our third-party information technology providers, our ISM addresses areas such as: ● Assessment and treatment of cyber and information security risks ● Assessment and treatment of informati…
MIRM	Mirum Pharmaceuticals, Inc.	72%	Reciprocal relationship from MIRM graph: Reciprocal relationship from PRQR graph: Reciprocal relationship from MIRM graph: future, any of which could limit the amounts that the U.S. federal governmen…
CRS	Carpenter Technology Corporation	62%	Reciprocal relationship from CRS graph: Reciprocal relationship from PRQR graph: Reciprocal relationship from CRS graph: Reciprocal relationship from PRQR graph: Reciprocal relationship from CRS grap…
WING	Wingstop Inc.	62%	Reciprocal relationship from WING graph: Reciprocal relationship from PRQR graph: Reciprocal relationship from WING graph: Reciprocal relationship from PRQR graph: Reciprocal relationship from WING g…

ProQR Therapeutics N.V. Debt Obligations

Instrument	Description	Confidence	Evidence
PRQR-DEBT	Debt stack $18.3M	90%	Market cache reports total debt of $18.3M.

ProQR Therapeutics N.V. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for ProQR Therapeutics N.V..

ProQR Therapeutics N.V. Ownership

Holder	Name	Confidence	Evidence
PRQR-OWNER-ADAGE-CAPITAL-PARTNERS-GP-L-L-C	ADAGE CAPITAL PARTNERS GP, L.L.C.	90%	13F overlay lists ADAGE CAPITAL PARTNERS GP, L.L.C. as top holder; 70 tracked holders.

ProQR Therapeutics N.V. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
BYSI	BeyondSpring Inc.	100.00	2
ARWR	Arrowhead Pharmaceuticals, Inc.	100.00	2
NVO	Novo Nordisk A/S	100.00	2
ALEC	Alector, Inc.	100.00	2
CTNM	Contineum Therapeutics, Inc.	100.00	2
ACRS	Aclaris Therapeutics, Inc.	100.00	2
DSGN	Design Therapeutics, Inc.	100.00	2
BCYC	Bicycle Therapeutics plc	100.00	2
SDGR	Schrödinger, Inc.	100.00	2
CMMB	Chemomab Therapeutics Ltd.	100.00	2
AXSM	Axsome Therapeutics, Inc.	100.00	2
DAWN	Day One Biopharmaceuticals Inc	100.00	2
CRS	Carpenter Technology Corporation	100.00	1	['customer']
ACIU	AC Immune SA	100.00	2
BIOA	BioAge Labs, Inc.	100.00	2
FHTX	Foghorn Therapeutics Inc.	100.00	2
AKTS	Aktis Oncology, Inc.	100.00	2
EDSA	Edesa Biotech, Inc.	100.00	2
ALNY	Alnylam Pharmaceuticals, Inc.	100.00	2
FDMT	4D Molecular Therapeutics, Inc.	100.00	2

ProQR Therapeutics N.V. Supply Chain